NUSAP1 -high patients with ACC, KIRC, KIRP, LUAD, and SKCM also showed a significant trend towards higher TNM stages.
← all excerpts
Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response.
1
—
—